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IMPORTANCE Maternal depression and anxiety can have deleterious and lifelong
consequences on child development. However, many aspects of the association of early brain
development with maternal symptoms remain unclear. Understanding the timing of potential
neurobiological alterations holds inherent value for the development and evaluation of future
therapies and interventions.
OBJECTIVE To examine the association between exposure to prenatal maternal depression
and anxiety symptoms and offspring white matter microstructure at 1 month of age.
DESIGN, SETTING, AND PARTICIPANTS This cohort study of 101 mother-infant dyads used a
composite of depression and anxiety symptoms measured in mothers during the third
trimester of pregnancy and measures of white matter microstructure characterized in the
mothers’ 1-month offspring using diffusion tensor imaging and neurite orientation dispersion
and density imaging performed from October 1, 2014, to November 30, 2016. Magnetic
resonance imaging was performed at an academic research facility during natural,
nonsedated sleep.
MAIN OUTCOMES AND MEASURES Brain mapping algorithms and statistical models were used
to evaluate the association between maternal depression and anxiety and 1-month infant
white matter microstructure as measured by diffusion tensor imaging and neurite orientation
dispersion and density imaging findings.
RESULTS In the 101 mother-infant dyads (mean [SD] age of mothers, 33.22 [3.99] years; mean
age of infants at magnetic resonance imaging, 33.07 days [range, 18-50 days]; 92 white
mothers [91.1%]; 53 male infants [52.5%]), lower 1-month white matter microstructure
(decreased neurite density and increased mean, radial, and axial diffusivity) was associated in
right frontal white matter microstructure with higher prenatal maternal symptoms of
depression and anxiety. Significant sex × symptom interactions with measures of white
matter microstructure were also observed, suggesting that white matter development may
be differentially sensitive to maternal depression and anxiety symptoms in males and females
during the prenatal period.
CONCLUSIONS AND RELEVANCE These data highlight the importance of the prenatal period to
early brain development and suggest that the underlying white matter microstructure is
associated with the continuum of prenatal maternal depression and anxiety symptoms.
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D epression and anxiety are common duringpregnancy.1-3 These disorders are estimated to affect7% to 20% of pregnant women4; however, many
resonance imaging (MRI) on their 1-month-old infants to
quantitatively characterize early white matter microstruc-
ture. Prenatal maternal symptoms were measured at 28 and
35 weeks’ gestation, and infant white matter microstructure
was evaluated using DTI and NODDI.30 Guided by previous
observations that suggest that prenatal exposure to mater-
nal depression and anxiety affects males and females
differently,31,32 we also investigated associations separately
for male and female infants.
Methods
Study Design and Participants
Mother-infant dyads (N = 149) participated in sessions as part
of an ongoing longitudinal study of the association between
early-life experience and infant brain development. Mothers
needed to be aged 18 to 40 years, have no diagnosis of psy-
chotic illnesses (eg, schizophrenia, bipolar or borderline
personality disorder), and no major autoimmune diseases or
infections during pregnancy. Infant inclusionary criteria con-
sisted of uncomplicated singleton birth, no preexisting neu-
rologic conditions or major head trauma, neonatal intensive
care unit stay limited to observation only (ie, no interven-
tions), and infant discharged from the hospital with the mother.
Criteria were confirmed through interviews with mothers and
collected medical records. All study procedures were in ac-
cordance with the institutional review board at the Univer-
sity of Wisconsin, Madison. Written informed consent was
obtained from each participating family.
Prenatal Maternal Depression and Anxiety Symptoms
Mothers completed the 10-item Edinburgh Postnatal Depres-
sion Scale (EPDS)33 and the 20-item State-Trait Anxiety Inven-
tory (STAI)34 at 28 and 35 weeks’ gestation. The state anxiety
scale of the STAI was used. The EPDS and STAI measure cur-
rent levels of symptoms, with higher scores indicative of higher
levels of symptoms. Internal consistency for mother self-
reported symptoms was high (α = .86 at 28 weeks and α = .84
at 35 weeks for depression and α = .85 at 28 weeks and α = .84
at 35 weeks for state anxiety). Depression and state anxiety
Key Points
Question Are prenatal maternal depression and anxiety
symptoms associated with individual variations of offspring white
matter microstructure?
Findings In this cohort study of 101 mother-infant dyads, prenatal
maternal depression and anxiety symptoms were associated with
infants’ white matter microstructure at 1 month of age. Moreover,
analyses suggest that prenatal maternal depression and anxiety
may be differentially associated with infant male and female
microstructure.
Meaning The prenatal environment is important to early brain
development, and underlying white matter microstructure may be
susceptible to the continuum of maternal depression and anxiety
symptom exposure during the prenatal period.
women reach only a subclinical threshold1 and are not for-
mally diagnosed. Nonetheless, such symptoms pose signifi-
cant risks not only to mothers but also to their offspring.5,6 The 
sequelae of depression and anxiety symptoms may affect the 
mother’s physiologic responses to distress,7 perturbing the in-
trauterine environment and consequently altering fetal and 
postnatal development.8,9 Mounting evidence links prenatal 
exposure to maternal depression and anxiety with poorer out-
comes in children, including increased negative reactivity,10 
emotional and behavioral difficulties,11 lower verbal IQ,12 and 
physical health problems.13 Origins of such maladaptive child 
outcomes likely have a neurobiological basis, but the extent 
and timing of neurodevelopmental alterations associated 
with maternal depression and anxiety symptoms are not well 
understood.
There is increasing recognition that prenatal maternal 
stress, depression, and anxiety affect the developing brain, par-
ticularly white matter microstructure. White matter is com-
posed of myelin and axons that connect brain regions and fa-
cilitate interneuronal communication14 and is continuously 
shaped throughout life.15-17 This prolonged maturation makes 
white matter susceptible to early-life influences, which may 
have cascading effects on subsequent development.18,19 Dif-
fusion tensor imaging (DTI) has been used to examine the as-
sociation of maternal depression and anxiety with white mat-
ter microstructure.20-25 Diffusion tensor imaging provides 
metrics of fractional anisotropy (FA), mean diffusivity (MD), 
axial diffusivity (AD), and radial diffusivity (RD), which char-
acterize properties of water diffusion in the brain that are sen-
sitive to white matter microstructure features.26,27
Nonhuman primate research has found widespread white 
matter alterations as a result of exposure to prenatal 
adversity.20-22 In humans, increased second-trimester and post-
partum maternal depression levels were negatively associ-
ated with white matter microstructure in offspring when as-
sessed at preschool ages.23 In neonates born to mothers with 
low and high levels of depression, researchers found lower FA 
and AD in the right amygdala,24 as well as variations of FA 
across limbic and prefrontal regions, including the right un-
cinate and inferior fronto-occipital fasciculi, insular, and para-
hippocampal white matter.25 Collectively, these studies23-25 
provide converging evidence that white matter may be vul-
nerable to prenatal maternal adversity. However, it is impor-
tant to further examine this influence over the continuum of 
prenatal maternal symptoms, including low and moderate lev-
els. Moreover, in previous studies,23-25 DTI was used to char-
acterize brain microstructure. Although informative, DTI lacks 
microstructural specificity.28,29 Techniques such as neurite ori-
entation dispersion and density imaging (NODDI)30 may pro-
vide improved specificity, allowing new insight into white mat-
ter alterations.
To further understand the association between prenatal 
maternal depression and anxiety symptoms and infant 
white matter microstructure, we examined mothers with a 
broad range of symptom severity and performed magnetic
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measures were strongly correlated within and across time
(Table 1), and a principal components analysis that incorpo-
rated the 4 measures indicated 1 principal component that ac-
counted for 69.5% of the variance attributed to individual
items. This robust depression and anxiety composite was used
in subsequent analyses, with higher scores indicative of higher
levels of depression and state anxiety symptoms.
MRI Data Acquisition
Magnetic resonance imaging was performed from October 1,
2014, to November 30, 2016, on a 3-T scanner (MR750 Discov-
ery scanner; General Electric) equipped with a 32-channel head
RF array coil (Nova Medical). Scanning occurred at 1 month of
age during natural, nonsedated sleep.35 As previously
described,36,37 a MedVac vacuum immobilization bag (CFI
Medical Solutions) and foam cushions were used to limit in-
trascan motion. Noise from the scanner was reduced by der-
ating gradient amplitudes and slew rates and using a sound-
attenuating bore insert, malleable ear plugs, and neonatal ear
covers (MiniMuff; Natus Medical Inc). Electrodynamic head-
phones (MR Confon) played white noise during image acqui-
sition.
Diffusion-weighted images (DWIs) were acquired using a
single-shot, spin-echo. echo-planar imaging pulse sequence.
The 10-minute protocol included 69 DWIs, with 9/18/36
diffusion-encoding gradient directions at b = 350/800/1500
seconds/mm2, respectively, and 6 with no (b = 0 seconds/
mm2) diffusion weighting. Additional imaging criteria con-
sisted of the following: in-plane resolution, 2 × 2 mm; slice
thickness, 2 mm; repetition time, 8400 milliseconds; echo
time, 94 milliseconds; and bandwidth, 3906 Hz per pixel.
Image Processing
The DWIs were manually assessed and individual volumes
dropped if artifacts were present. The DWIs were coregis-
tered to account for distortion, translation, and rotation from
bulk head motion and eddy currents.38 Gradient directions
were corrected for rotations.39 After removal of nonparen-
chyma signal (ie, 3dSkullStrip40,41), robust estimation of ten-
sors by outlier rejection42 (as part of the diffusion imaging in
Python Package43) estimated the diffusion tensors, and FA, MD,
RD, and AD maps were derived.44,45 Each of these tissue cri-
teria reflect quantities sensitive to the underlying microstruc-
ture: FA is a scalar quantity between 0 and 1 that describes the
degree of diffusion anisotropy, MD reflects total water mobil-
ity, AD describes diffusivity along the main fiber orientation,
and RD describes diffusivity perpendicular to the main fiber
axis.29,45
The NODDI model was also fit to the DWI data.30 The vol-
ume fraction of the intracellular or restricted diffusion com-
partment (νIC), the volume fraction of an isotropic diffusion
compartment (νISO), and the orientation dispersion index (ODI)
were estimated. Restricted diffusion is attributed to axons and
dendrites (neurites); thus, νIC is interpreted as an index of neu-
rite density, whereas cerebrospinal fluid or isotropic diffu-
sion is attributed to νISO. The ODI quantifies the angular varia-
tion of the neurite orientation (ie, dispersion and fanning) and
is sensitive to the degree of fiber coherence.30
The participants’ FA maps were aligned to a study-
specific template as previously described.36 The DTI and
NODDI variable maps were brought into study-specific tem-
plate space by applying the deformations and smoothed with
a 5-mm full-width, half-maximum Gaussian filter.
Statistical Analysis
Statistical analyses used general linear models (GLMs) to test
how prenatal maternal adversity (composite of depression and
anxiety symptoms) was associated with 1-month infant white
matter microstructure. Sex × symptom interaction and sex-
specific GLMs were also used to examine differential associa-
tions between prenatal maternal adversity and infant brain in
males and females. Voxel-wise GLMs were tested for each DTI
(FA, MD, RD, and AD) and NODDI (νIC and ODI) quantity and
restricted to white matter (eFigure 1 in the Supplement). Mul-
tiple comparisons were accounted for by using nonparamet-
ric permutation testing (FMRIB Software Library’s random-
ize tool and 10 000 permutations) and cluster-based
correction,46,47 with an initial cluster threshold of t>2.3 (ap-
proximately P < .01). Significance was defined as P < .05, clus-
ter corrected for familywise error rate.
Infant chronological age (corrected to a 40-week gesta-
tion), maternal educational level, total family income, and
breastfeeding status at 1 month were used as covariates to
control for potential confounding influences.36,48-51 Mean
volume-to-volume translation and rotation indexes were
computed for each participant52,53 and included to ascertain
that motion did not confound associations. Infant sex was
included as a covariate in analyses of the overall sample. In
Table 1. Correlation Between 28- and 35-Week Prenatal Maternal Depression and Anxiety Scores
Test
Pearson Correlation Coefficient, r
EPDS STAI
Composite
Score28 wk 35 wk 28 wk 35 wk
EPDS
28 wk NA 0.71 0.68 0.49 0.80
35 wk NA NA 0.52 0.61 0.76
STAI
28 wk NA NA NA 0.60 0.89
35 wk NA NA NA NA 0.84
Mean (SD)
[range]
5.98 (4.13) [0-19] 5.65 (3.89) [0-16] 10.68 (5.94) [1-34] 11.01 (5.48) [2-29] 0.00 (8.22)
Abbreviations: EPDS, Edinburgh
Postnatal Depression Scale; NA, not
applicable; STAI, State-Trait Anxiety
Inventory (state anxiety scale).
such as birth weight and length and head circumference at
birth, are also not related to diffusion measures from this
cohort36 and thus were not included.
Results
Of the 149 possible mother-infant dyads, data were missing for
46 infants, who did not sleep through the entire diffusion scan,
and 2 mothers, who did not complete all 4 adversity measures
at 28 and 35 weeks (eTable in the Supplement provides demo-
graphic information of mothers and infants with missing data),
resulting in an analysis sample of 101 mother-infant pairs (mean
[SD] age of mothers, 33.22 [3.99] years; mean age of infants at
MRI, 33.07 days [range, 18-50 days]; 92 white mothers [91.1%];
53 male infants [52.5%]) with successful DWI data and EPDS and
STAI reports. Table 2 provides demographic information for
mothers and their infants.
The mean (SD) EPDS and STAI scores are reported in Table 1.
The sample reported minimal to moderate levels of depres-
sion and anxiety,54 with 54 mothers (53.5%) reporting mini-
mal depressive symptoms (EPDS scores, 0-6), 42 mothers
(41.6%) meeting criteria for mild symptoms (EPDS scores, 7-13),
and 5 mothers (5.0%) meeting criteria for moderate depres-
sion symptoms (EPDS scores, 14-19). Six mothers reported EPDS
scores greater than 12, which is generally consistent with a di-
agnosis of major depressive disorder.33 Similarly, mothers re-
ported low to medium anxiety symptoms, with STAI scores
ranging from a mean of 4 to 28 of a possible range of 0 to 60.
The EPDS and STAI scores were correlated within and across
time (Table 1).
Association Between Maternal Depression and Anxiety
Symptoms and White Matter Microstructure
Positive associations were observed between the maternal de-
pression and anxiety symptoms composite and MD, RD, and
AD across white matter regions. Clusters were localized to the
right hemisphere and included the anterior, superior, and pos-
terior corona radiata, external capsule, and white matter un-
derlying the dorsolateral prefrontal cortex (Figure 1). More ma-
ternal depression and anxiety symptoms were also associated
with higher right-hemisphere RD in the superior longitudinal
fasciculus and optic radiations. Negative associations be-
tween prenatal maternal symptoms and FA were observed, in-
cluding the external capsule, anterior internal capsule, supe-
rior corona radiata, and white matter of the superior-parietal
and prefrontal cortices (eFigure 2 in the Supplement). The as-
sociations were not observed to be significant based on the
specified P<.05 cluster-corrected criteria but were suggestive
of an association at the P<.10 cluster-corrected level.
Maternal depression and anxiety symptoms were also as-
sociated with decreased νIC, particularly in frontal brain re-
gions (Figure 2). Associations were stronger for maternal symp-
toms in the right hemisphere and included white matter of the
superior, middle, and inferior frontal gyrus and the anterior
and superior corona radiata. Higher maternal symptoms were
additionally associated with lower νI C in the right-
hemisphere external capsule and bilateral white matter of the
Table 2. Sociodemographic Characteristics of the 101
Mother-Infant Dyads
Characteristic Findinga
Mother age at birth, mean (SD), y 33.22 (3.99)
Mother educational level, mean (SD), y 17.79 (2.45)
Total family income, US $
30 001-40 000 4 (4.0)
40 001-50 000 8 (7.9)
50 001-60 000 6 (5.9)
60 001-70 000 6 (5.9)
70 001-80 000 12 (11.9)
80 001-90 000 15 (14.9)
90 001-100 000 7 (6.9)
100 001-150 000 30 (29.7)
150 001-200 000 7 (6.9)
>200 000 6 (5.9)
Mothers’ marital status




Data not reported or missing 5 (5.0)
Mothers' race
African American/black 2 (2.0)
Asian 3 (3.0)
White 92 (91.1)
Native Hawaiian or other Pacific Islander 2 (2.0)
Mixed race 1 (1.0)
Not reported 1 (1.0)
Mothers' medication status








Infant age at MRI, mean (range), d 33.07 (18-50)
Gestation, mean (SD), wk 39.56 (1.40)
Birth weight, mean (SD), g 3470 (531)
Birth length, mean (SD), in 51.38 (2.90)
Head circumference, mean (SD), cm 13.66 (0.57)
Apgar score, mean (SD), min
1 8.2 (1.4)
5 8.9 (0.6)
Breastfeeding status at 1 mo
Exclusively breastfed 87 (86.1)
Exclusively formula fed 3 (3.0)
Mixed 11 (10.9)
Abbreviation: MRI, magnetic resonance imaging.
a Data are presented as number (percentage) of mothers or infants unless
otherwise indicated.
separate analyses, prenatal maternal medication use was not 
observed to alter associations with diffusion measures and 
therefore was not included as a covariate. Other variables,
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frontolateral orbital gyrus and precentral and postcentral gy-
rus. No associations were observed with ODI across the whole
group.
Association of Infant Sex With Maternal Symptoms
and Brain Microstructure
Analyses further examined whether prenatal maternal depres-
sion and anxiety was differentially associated with infant
microstructure in males and females. A significant sex × symp-
tom interaction was found for FA in regions including the co-
rona radiata, posterior internal capsule, sagittal stratum, and
stria terminalis (Figure 3A). A sex × symptom interaction was
also found for νIC (Figure 3B) and ODI (Figure 3C) in the sag-
ittal stratum, posterior thalamic radiations, and white matter
adjacent to the hippocampus. These results suggest differing
associations between males and females, with lower FA and
νIC in females and higher FA and νIC in males exposed to higher
levels of maternal depression and anxiety. Separate analyses
of the DTI and NODDI measures in males and females re-
vealed several notable associations with maternal symptoms
across differential white matter regions (eFigure 3 in the
Supplement); however, these associations did not remain sig-
nificant after accounting for multiple comparisons.
Discussion
The prenatal period is a critical phase of neurodevelopment, with
much of the brain’s foundational infrastructure developing dur-
ing this time.16,17 This period is also susceptible to genetic and
environmental factors that can alter the offspring’s lifelong tra-
jectory of brain development. We provide evidence that pre-
natal exposure to maternal depression and anxiety symptoms
is associated with an infant’s white matter microstructure as-
sessed at 1 month. Moreover, although we observed signifi-
cant alterations across infants, the associations between pre-
natal symptoms and white matter were different in male and
female offspring. Our findings complement increasing litera-
ture that draws attention to the importance of the prenatal pe-
riod for early brain development19,55 and suggest that the in-
fant neural microstructure may be sensitive to prenatal maternal
depression and anxiety symptoms.
Prenatal maternal depression and anxiety symptoms were
associated with higher DTI diffusivities (MD, RD, and AD) and
lower νIC. These findings are consistent with previous
Figure 1. Association Between Prenatal Maternal Depression






Magnetic resonance imaging shows voxelwise associations between prenatal
maternal depression and anxiety composite and radial diffusivity (RD) (top),
mean diffusivity (MD) (middle), and axial diffusivity (AD) (bottom), with
increased RD, MD, and AD in right-hemispheric white matter. Scale indicates
cluster-corrected P values.
Figure 2. Association of Increased Prenatal Maternal Depression and Anxiety Symptoms




R L Neurite orientation dispersion and
density imaging intracellular volume
fraction revealed white
matter–spanning bilateral regions of
the prefrontal cortex, including white
matter of the superior, middle, and
inferior frontal gyrus and the anterior
and superior corona radiata, that was
negatively associated with the
prenatal maternal depression and




matter16,17,57-61 and the likelihood that prenatal and postnatal
influences within the first month contribute to shaping brain
connectivity, it is likely that any developmental outcome that
we study is the joint product of prenatal and postnatal influ-
ences. With sufficiently large sample sizes, it will be possible
to track neonates and toddlers who may be exposed to prena-
tal maternal depression and anxiety symptoms at different de-
velopmental stages to determine whether prenatal exposure
contributes additional variance to subsequent vulnerability
above that contributed by postnatal influences.
We also found differing associations of prenatal maternal
depression and anxiety symptoms with white matter micro-
structure in males and females. Such associations may be linked
to differing time courses of white matter development, with
white matter in females developing earlier than in males.59,62,63
The sex differences that we found are consistent with our ear-
lier work showing that early-life stress and cortisol are asso-
ciated with altered connectivity relations in females but not
males.64 Moreover, Wen et al65 found the volume and FA of
the right amygdala to be positively correlated with maternal
depressive symptoms in 4.5-year-old female participants but
not in male participants. These findings do not imply that white
matter in males is resilient to prenatal maternal symptoms; in-
stead, they suggest the possibility that such microstructural
alterations in males may be detected at a different time dur-
ing development. Whether the sex differences observed in our
study are associated with subsequent development of sex dif-
ferences in the prevalence of depression66 requires further lon-
gitudinal study.


















































































Fractional anisotropy (FA) (A and D), neurite orientation dispersion and density
imaging (NODDI) intracellular volume fraction (VIC) (B and E), and orientation
dispersion index (ODI) (C and F) were observed to be differentially associated
with prenatal maternal adversity in the white matter of males and females, with
associations localized within left-hemisphere white matter, including
superior-frontal white matter, corona radiata, and splenium of the corpus
callosum. Representative plots depict this differing association between males
and females, with scatterpoints corresponding to individual mean criteria
(FA, VIC, and ODI) and the solid lines corresponding to the lines of best fit with
prenatal maternal depression and anxiety symptoms composite. DTI indicates
diffusion tensor imaging.
studies23-25 that examined associations between maternal de-
pressive symptoms and white matter. The nonsignificant nega-
tive associations between FA and maternal depression and 
anxiety that we observed are consistent with results from the 
only other study25 to date that has examined similar associa-
tions in neonates.
Conversely, our findings differ from those of Lebel et al,23 
who found a negative association between maternal depressive 
symptoms and DTI diffusivity measures in preschool-aged chil-
dren. This discrepancy may be attributable to the age differences 
between the sample in our study and the sample of Lebel et al,23 
highlighting the potential importance of developmental changes 
on these associations. Future longitudinal studies are necessary 
to understand the influence of prenatal maternal adversity ex-
posure across differing developmental stages.
Higher diffusivity (MD, RD, and AD) and lower FA and νIC 
are generally assumed to represent poorer white matter 
microstructure26,29 and may reflect disrupted white matter 
development.17 Although our findings are based on associa-
tions, they suggest that prenatal maternal symptoms may dis-
rupt white matter development in neonates and potentially 
have a long-lasting bearing on child development. In particu-
lar, many of the white matter regions that were altered are criti-
cal for establishing connectivity within brain regions impli-
cated in executive function, cognitive control, and emotion 
regulation.56 Maternal depression and anxiety are known to 
adversely affect child behavioral and emotional outcomes11; 
our findings show that neural pathways may differ in these chil-
dren as well. Because of the rapid postnatal maturation of white
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The neural mechanisms that underlie associations be-
tween microstructural measures and maternal symptoms re-
main unclear. Axonal formation and growth of long-distance
white matter bundles occur almost completely during the sec-
ond trimester of pregnancy,17 whereas myelination begins
during the second trimester of pregnancy and continues
throughout adolescence and early adulthood.15,17 However,
prenatal exposure to maternal depression and anxiety may
affect each of these processes. Because diffusion measures
are sensitive to a broad range of microstructural features,28,29,67
future work should consider using techniques that are sensi-
tive to specific tissue properties.45
Limitations
This study has several limitations. First, although our find-
ings suggest a possible association between prenatal mater-
nal adversity and infant white matter, our study design
limits our ability to distinguish environmental and genetic
influences. Differentiation of such influences may be pos-
sible in studies of infant twins. Second, we recognize the
difficultly of distinguishing prenatal and postnatal environ-
mental influences. Although we acquired neuroimaging
data at 1 month and controlled for factors that shape postna-
tal neurodevelopment,36,48-51 postnatal influences have
already begun to affect development by 1 month. Third, the
cross-sectional nature of our data restricts our ability to
examine trajectories of infant brain development in associa-
tion with prenatal maternal depression and anxiety symp-
toms. The current data allow us to establish a 1-month time
point from which we can track the influence of later postna-
tal experiences. Furthermore, other distal factors may also
be related to maternal depression and anxiety,4,68-70 which
may in turn affect early brain development.50,71-73
Experiential factors are important influences that shape
early brain development. Our results complement existing lit-
erature that reports an association between prenatal depres-
sion and anxiety with offspring brain development, specifi-
cally white matter microstructure. However, we cannot
conclude that the association between prenatal depression and
anxiety is directly related in our study; that is, the cross-
generational association could conceivably be genetically me-
diated. Because our sample was recruited from the commu-
nity, our findings have important implications for a broader
population of mothers than clinic-based samples. The fact that
subclinical symptoms predict alterations in early brain devel-
opment underscores the importance of early intervention even
in mothers experiencing mild depression and anxiety symp-
toms during pregnancy.
Conclusions
These findings draw attention to the importance of the pre-
natal period in early brain development. If replicated, our find-
ings also invite more mechanistic studies of early processes that
underlie the development of child behavior problems. More
speculatively, they also might provide a rationale for the pos-
sibility that treatment of maternal depression and anxiety dur-
ing pregnancy could mitigate how maternal adversity affects
infant brain development.
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